Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
| MER Indicator |
MER description |
Target Fiscal Year |
Target |
| PMTCT_ART |
New on ART |
2019 |
10 |
| PMTCT_ART |
Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy |
2019 |
10 |
| PMTCT_ART |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2019 |
12 |
| PMTCT_EID |
By infants who received a virologic test within 2 months of birth |
2019 |
7 |
| PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2019 |
7 |
| PMTCT_EID |
Sum of Infant Age disaggregates |
2019 |
7 |
| PMTCT_STAT |
25-29, Female |
2019 |
3 |
| PMTCT_STAT |
25-29, Female, Known at Entry Positive |
2019 |
3 |
| PMTCT_STAT |
30-34, Female |
2019 |
6 |
| PMTCT_STAT |
30-34, Female, Known at Entry Positive |
2019 |
6 |
| PMTCT_STAT |
35-39, Female |
2019 |
2 |
| PMTCT_STAT |
35-39, Female, Known at Entry Positive |
2019 |
2 |
| PMTCT_STAT |
40-49, Female |
2019 |
1 |
| PMTCT_STAT |
40-49, Female, Known at Entry Positive |
2019 |
1 |
| PMTCT_STAT |
Number of new ANC and L&D clients |
2019 |
12 |
| PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2019 |
12 |
| PMTCT_STAT_den |
25-29, Female |
2019 |
3 |
| PMTCT_STAT_den |
30-34, Female |
2019 |
6 |
| PMTCT_STAT_den |
35-39, Female |
2019 |
2 |
| PMTCT_STAT_den |
40-49, Female |
2019 |
1 |
| TX_CURR |
25-29, Female, Positive |
2019 |
22 |
| TX_CURR |
25-29, Male, Positive |
2019 |
9 |
| TX_CURR |
30-34, Female, Positive |
2019 |
30 |
| TX_CURR |
30-34, Male, Positive |
2019 |
15 |
| TX_CURR |
35-39, Female, Positive |
2019 |
36 |
| TX_CURR |
35-39, Male, Positive |
2019 |
19 |
| TX_CURR |
40-49, Female, Positive |
2019 |
54 |
| TX_CURR |
40-49, Male, Positive |
2019 |
57 |
| TX_CURR |
Age/Sex: 10-14 Female |
2019 |
10 |
| TX_CURR |
Age/Sex: 10-14 Male |
2019 |
13 |
| TX_CURR |
Age/Sex: 15-19 Female |
2019 |
4 |
| TX_CURR |
Age/Sex: 15-19 Male |
2019 |
1 |
| TX_CURR |
Age/Sex: 20-24 Female |
2019 |
3 |
| TX_CURR |
Age/Sex: 20-24 Male |
2019 |
1 |
| TX_CURR |
Age/Sex: 50+ Female |
2019 |
41 |
| TX_CURR |
Age/Sex: 50+ Male |
2019 |
28 |
| TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2019 |
343 |
| TX_CURR |
Sum of age/sex disaggregates |
2019 |
5 |
| TX_NEW |
25-29, Female, Positive |
2019 |
3 |
| TX_NEW |
25-29, Male, Positive |
2019 |
3 |
| TX_NEW |
30-34, Male, Positive |
2019 |
6 |
| TX_NEW |
By Age/Sex: 1-9 |
2019 |
1 |
| TX_NEW |
By Age/Sex: 50+ Female |
2019 |
1 |
| TX_NEW |
By Age/Sex: 50+ Male |
2019 |
1 |
| TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2019 |
15 |
| TX_NEW |
Sum of Age/Sex disaggregates |
2019 |
2 |
| TX_RET |
Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2019 |
3 |
| TX_RET |
Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2019 |
2 |
| TX_RET |
Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2019 |
10 |
| TX_RET |
Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2019 |
28 |
| TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2019 |
43 |
| TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2019 |
45 |
| TX_RET_den |
Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2019 |
3 |
| TX_RET_den |
Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2019 |
2 |
| TX_RET_den |
Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2019 |
11 |
| TX_RET_den |
Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2019 |
29 |
| VMMC_CIRC |
30-34, Male |
2019 |
184 |
| VMMC_CIRC |
35-39, Male |
2019 |
105 |
| VMMC_CIRC |
40-49, Male |
2019 |
53 |
| VMMC_CIRC |
By Age: 10-14 |
2019 |
920 |
| VMMC_CIRC |
By Age: 15-19 |
2019 |
789 |
| VMMC_CIRC |
By Age: 20-24 |
2019 |
264 |
| VMMC_CIRC |
By Age: 25-29 |
2019 |
263 |
| VMMC_CIRC |
By Age: 50+ |
2019 |
53 |
| VMMC_CIRC |
By circumcision technique: Surgical VMMC |
2019 |
2,630 |
| VMMC_CIRC |
Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period |
2019 |
2,631 |
| VMMC_CIRC |
Sum of age disaggregates (FY15-Current) |
2019 |
2,289 |
| VMMC_CIRC |
Sum of age disaggregates (Prior to FY15) |
2019 |
2,026 |
